Lung cancer screening: Is it time for a change in policy?

Article Type
Changed
Wed, 07/18/2018 - 10:57
Display Headline
Lung cancer screening: Is it time for a change in policy?
Article PDF
Author and Disclosure Information

Peter Mazzone, MD, MPH
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Moulay Meziane, MD
Head, Section of Chest Radiology, Department of Diagnostic Radiology and Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Nancy Obuchowski, PhD
Department of Diagnostic Radiology and Department of Quanititative Health Sciences, Cleveland Clinic

Muzaffar Ahmad, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Tarek Mekhail, MD, MS
Department of Solid Tumor Oncology, Cleveland Clinic

Address: Peter Mazzone, MD, Department of Pulmonary, Allergy, and Clinical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mazzonp@ccf.org

Dr. Mekhail has indicated that he is on the speaker’s bureaus of the Genentech, Sanofi-Aventis, and Eli Lilly corporations.

Issue
Cleveland Clinic Journal of Medicine - 74(6)
Publications
Topics
Page Number
441-448
Sections
Author and Disclosure Information

Peter Mazzone, MD, MPH
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Moulay Meziane, MD
Head, Section of Chest Radiology, Department of Diagnostic Radiology and Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Nancy Obuchowski, PhD
Department of Diagnostic Radiology and Department of Quanititative Health Sciences, Cleveland Clinic

Muzaffar Ahmad, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Tarek Mekhail, MD, MS
Department of Solid Tumor Oncology, Cleveland Clinic

Address: Peter Mazzone, MD, Department of Pulmonary, Allergy, and Clinical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mazzonp@ccf.org

Dr. Mekhail has indicated that he is on the speaker’s bureaus of the Genentech, Sanofi-Aventis, and Eli Lilly corporations.

Author and Disclosure Information

Peter Mazzone, MD, MPH
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Moulay Meziane, MD
Head, Section of Chest Radiology, Department of Diagnostic Radiology and Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Nancy Obuchowski, PhD
Department of Diagnostic Radiology and Department of Quanititative Health Sciences, Cleveland Clinic

Muzaffar Ahmad, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Tarek Mekhail, MD, MS
Department of Solid Tumor Oncology, Cleveland Clinic

Address: Peter Mazzone, MD, Department of Pulmonary, Allergy, and Clinical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mazzonp@ccf.org

Dr. Mekhail has indicated that he is on the speaker’s bureaus of the Genentech, Sanofi-Aventis, and Eli Lilly corporations.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 74(6)
Issue
Cleveland Clinic Journal of Medicine - 74(6)
Page Number
441-448
Page Number
441-448
Publications
Publications
Topics
Article Type
Display Headline
Lung cancer screening: Is it time for a change in policy?
Display Headline
Lung cancer screening: Is it time for a change in policy?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Drug-induced lung disease

Article Type
Changed
Tue, 01/29/2019 - 13:10
Display Headline
Drug-induced lung disease
Article PDF
Author and Disclosure Information

Metin Özkan, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Raed A. Dweik, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Muzaffar Ahmad, MD
Department of Pulmonary and Critical Care Medicine, Chairman, Division of Medicine, Cleveland Clinic

Address: Raed A. Dweik, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; dweikr@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 68(9)
Publications
Topics
Page Number
782-785, 789-795
Sections
Author and Disclosure Information

Metin Özkan, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Raed A. Dweik, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Muzaffar Ahmad, MD
Department of Pulmonary and Critical Care Medicine, Chairman, Division of Medicine, Cleveland Clinic

Address: Raed A. Dweik, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; dweikr@ccf.org

Author and Disclosure Information

Metin Özkan, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Raed A. Dweik, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Muzaffar Ahmad, MD
Department of Pulmonary and Critical Care Medicine, Chairman, Division of Medicine, Cleveland Clinic

Address: Raed A. Dweik, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; dweikr@ccf.org

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(9)
Issue
Cleveland Clinic Journal of Medicine - 68(9)
Page Number
782-785, 789-795
Page Number
782-785, 789-795
Publications
Publications
Topics
Article Type
Display Headline
Drug-induced lung disease
Display Headline
Drug-induced lung disease
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media